Maintaining plasma calcium levels within a narrow range is of vital importance for many physiological functions. Therefore, calcium transport processes in the intestine, bone and kidney are tightly regulated to fine-tune the rate of absorption, storage and excretion. The TRPV5 and TRPV6 calcium channels are viewed as the gatekeepers of epithelial calcium transport. Several calciotropic hormones control the channels at the level of transcription, membrane expression, and function. Recent technological advances have provided the first near-atomic resolution structural models of several TRPV channels, allowing insight into their architecture. While this field is still in its infancy, it has increased our understanding of molecular channel regulation and holds great promise for future structure-function studies of these ion channels. This review will summarize the mechanisms that control the systemic calcium balance, as well as extrapolate structural views to the molecular functioning of TRPV5/6 channels in epithelial calcium transport.
Introduction
The transient receptor potential (TRP) superfamily of ion channels was founded with the characterization of its first member in Drosophila melanogaster [1, 2] . By that time, the locus had been the object of investigation for over a decade, following the discovery of a visually impaired Drosophila mutant that exhibits a characteristic retinal electrical response to stimulation with bright light [3] . Soon after the discovery of the initial trp locus in Drosophila, multiple mammalian trp orthologues were reported in rapid succession. Currently, the TRP channel superfamily is made up of six mammalian subfamilies of ion channels; canonical (TRPC), melastatin (TRPM), vanilloid (TRPV), polycystin (TRPP), ankyrin (TRPA) and mucolipin (TRPML), categorized based on sequence homology [4] [5] [6] . Most members of the superfamily consist of six transmembrane domains, a pore-forming loop between the fifth and the sixth transmembrane domain, and large intracellular amino-and carboxy-terminal regions that govern channel activity [7, 8] . Functional TRP channels require homo-or heterotetrameric organization of individual protein subunits. Heterotetrameric assembly adds new functional diversity to the TRP channel family and occurs both within and between subfamilies, although channel formation with members of the same subfamily is most commonly observed [9, 10] .
TRP channels have myriad functions in cell biology, including migration, proliferation and survival. They play roles in carcinogenesis, immunological processes, tissue homeostasis, and are prominently present in pathways of sensory transduction and electrolyte homeostasis [11] [12] [13] . All TRP channels are cation permeable channels and exhibit at least some calcium conductance, exerting their function mostly by facilitating spatiotemporal calcium signalling events [11] . The widespread presence of TRP channels in sensory cascades corresponds with their ability to integrate multiple signals from the environment. The polymodal nature of each channel tightly modulates the passage of calcium and other ions to control timing and localization of the ion flux and downstream signalling processes [14, 15] . As such, TRP channel activity is best viewed as the sum of all activity-modulating factors at any given moment in time. Finding common TRP channel activators however has proven to be difficult, since the enormous diversity in physiological functions and rather low sequence homology has led to subfamily-or even member-specific activators. However, there are a few shared characteristics in the activation mechanisms for most TRP channels. A large fraction can be activated directly by the binding of specific ligands, such as vanilloid compounds, endogenous lipids, ATP, and select medications, to binding pockets on the channel surface. Indirect activation that arises downstream of receptor-mediated signalling, either via G-protein coupled receptors (GPCR) or receptor tyrosine kinases, also controls the activity of many TRP channels. Finally, several TRP channels are activated by biophysical mechanisms such as voltage, temperature and stretch [14] . Interestingly, mechanical gating, caused by deformation of the plasma membrane, was proposed recently as a universal activation mechanism for all TRP channels, although additional evidence is needed to substantiate this claim [16] .
The polymodal activity profile of TRP channels makes them perfect candidates to serve as regulated passageway through the otherwise impermeable plasma membrane of epithelial cells. Indeed, TRP channels are increasingly recognized as key players in both ion transport and signalling processes in kidney epithelia [17] . Two TRP channels, TRPV5 and TRPV6, have evolved into highly selective ion channels that partake in the process of epithelial calcium transport, contributing significantly to the maintenance of human calcium homeostasis [18] . A vital process, since disturbances in calcium homeostasis can cause major health problems, including stone formation, bone disorders, tetany and electrocardiographic aberrations. Epithelial calcium transport is tightly regulated to ensure that the combined processes of intestinal calcium absorption, dynamic storage in bone and urinary excretion maintain serum calcium levels within a narrow range (2.2-2.5 mmol/L).
In general, calcium transport over the epithelial barriers of intestine and kidney can be divided into paracellular passive transport and transcellular active transport. The latter is a regulated process involving three steps; apical entry of calcium into epithelial cells via TRPV5 or TRPV6, immediate binding of calcium by calbindin-D 9k and calbindin-D 28K which transport calcium to the basolateral membrane, and extrusion through the plasma membrane calcium ATPases (PMCA1 and PMCA4) and sodium-calcium exchanger isoform 1 (NCX1) [19] . TRPV5 and TRPV6 are co-expressed in intestinal and renal epithelia and are able to form heterotetrameric channels. TRPV5 is the main isoform in renal epithelia, whereas TRPV6 is the main isoform in the intestines [20] . Of note, TRPV5 expression is restricted to kidney while TRPV6 is more ubiquitously expressed.
This review summarizes the current understanding of calcium homeostasis and the interconnected network of endocrine signals that regulates calcium transport in bones, kidney and intestine. We pay special attention to the contributions of TRPV5-and TRPV6-mediated calcium transport, illustrating the characteristic polymodal TRP channel activity profile. Afterwards, the focus shifts to recent advances in the field of structural biology. The availability of structural density maps for several members of the TRPV subfamily, most notably TRPV6, allows for a deeper insight into the molecular mechanisms of epithelial calcium transport. We provide an overview of the structural elements of TRPV channels and how these may control selective calcium transport. Finally, this review also explores remaining gaps in our current knowledge and indicates questions for future study.
Calcium homeostasis

Feedback is key; interacting calciotropic hormones and their effect on mineral balance
Serum calcium levels are in a constant state of flux due to dietary availability and the dynamic nature of calcium transport. When plasma calcium levels change, the human body rapidly responds by tweaking the relative contributions of the calciotropic hormones to reflect the current calcium status. Almost immediately, parathyroid hormone (PTH), vitamin D, fibroblast growth factor 23 (FGF23) and Klotho, start to normalize plasma calcium levels by promoting calcium retention or wasting, dependent on the body's needs. Concerted negative and positive feedback loops exist within this hormonal network, and each member controls the activity of the others (Fig. 1) . In short, PTH and vitamin D are the body's most important defense mechanisms against reduced calcium availability, and shift the equilibrium of calcium transport towards the plasma compartment. A decline in plasma calcium levels activates the calcium-sensing receptor (CaSR) in the parathyroid gland, which stimulates the release of PTH into the bloodstream. When present in the systemic circulation, PTH regulates calcium transport processes in bones and kidneys and stimulates the conversion of vitamin D to its biologically active form 1,25(OH) 2 D 3 [21] . This process takes place in the renal epithelial cells of the proximal tubule and is catalyzed by 25(OH)D 1α-hydroxylase (CYP27B1), a member of the cytochrome P450 enzyme system [22] . In turn, 1,25(OH) 2 D 3 enters the bloodstream and increases the plasma concentrations of calcium as well as phosphate, by enhancing the expression of calcium and phosphate transporters in kidney, bone, and intestine (for an extensive review, see [23] [24] . The feedback loop between 1,25(OH) 2 D 3 and FGF23 allows crosstalk between bone and kidney and maintains bone integrity. Furthermore, FGF23 controls calcium homeostasis by regulating the expression of PTH in the parathyroid gland [24] .
The stimulatory effects of PTH on plasma calcium levels
In healthy adults, around 98% of all calcium is present as hydroxyapatite crystals within bone tissue. Osteoblasts stimulate the storage of calcium through the formation of new bone matrix whereas osteoclasts release calcium by breaking down bone matrix. Within bone, PTH enhances the efflux of calcium (and phosphate) to the blood compartment through two separate mechanisms. First, the presence of PTH shifts the equilibrium for bone mineralization and increases the calcium flux from the mineralized compartment to the extracellular fluid compartment, through a yet unknown mechanism [25] . At the same time, PTH upregulates the expression of RANKL (receptor activator of nuclear factor kappa-B ligand), a member of the TNF cytokine family, within osteoblast cells [26] . These cells then excrete RANKL, which binds its receptor (RANK) on the surface of osteoclasts, stimulating their differentiation and bone-resorbing activity to free up even more calcium and phosphate from the bone matrix. Expression of the TRP channels; TRPV4, TRPV5 and TRPV6 has been confirmed in osteoclasts, where they play roles in bone architecture and osteoclast differentiation and activity [27] . Mutations in TRPV4 are the underlying cause of several forms of congenital skeletal dysplasia disorders in which endochondral osteogenesis is affected [28] . To this date, no bone disorders have been linked to mutations in TRPV5 or TRPV6, although their respective knockout mouse models do display bone abnormalities. Trpv5 −/− mice have reduced trabecular and cortical bone thickness, combined with an increase in osteoclast numbers and osteoclast surface area [29] . Contrary to what these observations suggest, Trpv5 −/− osteoclast cultures display significantly lower bone resorption levels compared to wild type [30] . A study with human bone marrow-derived osteoclast cultures proposed TRPV5 as a mediator of RANKL signaling, showing that siRNA knockdown of TRPV5 almost completely abrogates the calcium influx that is required for the final stages of osteoclast differentiation [27, 31] . A later study demonstrated that TRPV5 modulation of RANKL-signaling is further regulated by estrogen, a pathway that may play a critical role in postmenopausal osteoporosis [32] . The phenotype of Trpv6 −/− mice is highly similar to the Trpv5 knockout, with increased osteoclast numbers and surface area, and reduced osteoclast activity [33] . Remarkably, no changes in bone microarchitecture or mineralization were observed in a mouse model with a non-functional Trpv6 D541A/D541A mutant, which suggests that additional factors mediate the bone phenotype observed in full TRPV6 knockout mice [34] . In conclusion, the role of TRPV6 in bone metabolism and osteoclast function is not yet fully elucidated and warrants further exploration. Additionally, the exact molecular link between RANKL signaling and TRPV5-mediated calcium entry into osteoclasts is an interesting target for future research.
Within the kidney, binding of PTH to its receptor PTH1R enhances reabsorption of calcium by increasing the expression of several calciotropic genes in the distal part of the nephron, most notably TRPV5 [35] . In addition, PTH1R can induce rapid changes in calcium transport through activation of intracellular signaling cascades [36] . On one hand, it activates phospholipase C that cleaves phospholipid phosphatidylinositol 4.5-bisphosphate (PIP 2 ) into diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP 3 ), which in turn activate protein kinase C (PKC). PKC phosphorylation on TRPV5 was shown to inhibit channel retrieval from the plasma membrane as a result of decreased caveolae-mediated endocytosis of the channels [37] . On the other hand, PTH1R signaling increases the concentration of intracellular cyclic AMP (cAMP) which activates protein kinase A (PKA). De Groot et al. have shown that the molecular target of PTH-mediated PKA activation in TRPV5 is threonine 709 (T 709 ). In a follow-up study, they postulated a model in which calmodulin negatively regulates channel activity until PTH stimulation of PKA leads to phosphorylation of T
709
, causing a loss of calmodulin binding and an increase in single channel activity [38] . Direct PKC/PKA phosphorylation of TRPV6 has not been reported to our knowledge, although it has been shown to play an indirect role in channel regulation [39, 40] . It is important to note that PKC and PKA are downstream of a very large group of surface receptors called the GPCRs. As a result of this, many other factors that bind GPCRs, such as bradykinin, plasmin and tissue kallikrein also regulate TRPV5 in various ways. Taken together, current literature suggests that PKC/PKA phosphorylation modulates TRPV5 (and TRPV6) activity in a site-specific manner, capable of either stimulating or inhibiting the channel based on where phosphorylation took place, and further study is needed to understand how phosphorylation balances the channel activity in healthy and pathogenic situations.
Vitamin D and intestinal calcium absorption:
The hormone 1,25(OH) 2 D 3 binds the vitamin D receptor/retinoic X receptor (VDR/RXR) heterodimer, which translocates to the nucleus to regulate transcription of a multitude of genes involved in calcium homeostasis, carcinogenesis and immunology [41] . The physiological function of 1,25(OH) 2 D 3 and the VDR/RXR mainly involves upregulation of calcium transporting genes in the intestines and, to a lesser extent, in bone and kidney. Our current understanding is that paracellular transport is the predominant form of calcium absorption in the intestines and that the transcellular pathway contributes little (8-10%) to intestinal calcium absorption under physiological conditions. However, the transcellular pathway can be significantly enhanced in times of calcium depletion, predominantly in the duodenum [42] . There is a strong correlation between transcellular calcium transport efficiency over the intestinal epithelial layer and the TRPV6 and calbindin-D 9k expression levels along the various segments of the intestines, pointing to a central role for these proteins in the transcellular pathway. Furthermore, it was shown that TRPV6 and calbindin-D 9k expression is heavily dependent on 1,25(OH) 2 D 3 stimulation [43] . Thus, researchers accepted a model in which TRPV6 and calbindin-D 9k facilitate transcellular calcium transport through the enterocyte under the governance of 1,25(OH) 2 D 3 . More recently, this concept has been challenged by the generation of Trpv6 and calbindin-D 9k knockout mice. Surprisingly enough, both mouse models retain their ability to significantly increase transcellular intestinal calcium absorption in response to a low calcium diet, albeit considerably weaker in Trpv6 −/− mice [44, 45] . Furthermore, treating these mice with 1.25(OH) 2 D 3 stimulates duodenal transcellular calcium transport to levels that are comparable to wildtype littermates [44] . On the other hand, a double knockout mouse (Trpv6 Most likely, the exact conditions that require active involvement of TRPV6 are still incompletely characterized. In the future, researchers should focus on deciphering the molecular mechanisms that control intestinal calcium transport through TRPV6, especially since altered TRPV6 expression has been linked to several intestinal cancers and inflammatory diseases like Crohn's disease [47, 48] .
In the kidney, 1,25(OH) 2 D 3 also plays a role in calcium reabsorption, specifically on the active transcellular transport pathway in the distal convoluted tubule. Here, 1,25(OH) 2 D 3 increases the expression of several calcium transporting genes, including TRPV5, Calbindin-D 28K and NCX1. A knockout mouse of Cyp27b1 displayed reduced expression of all above-mentioned genes and treatment with 1,25(OH) 2 D 3 restored expression to wild type levels [49] . Because TRPV5 is the gatekeeper of transcellular calcium reabsorption in the kidney, one would expect a significant reduction in its expression in the absence of VDR signaling. Surprisingly, even though renal calcium reabsorption is impaired in Vdr null mice, only Calbindin-D 9K expression is reduced [23] .
The FGF23-Klotho axis as a coordinator of electrolyte transport in bone and kidney:
The classical concept of calcium homeostasis, with the PTH-vitamin D axis as the sole regulator, does not fully capture the intricacies of calcium handling by the human body. Multiple studies have highlighted the contributions of an additional hormone axis, consisting of FGF23 and Klotho, which regulates urinary calcium and phosphate excretion, and provides a negative feedback loop that modulates the actions of PTH and vitamin D [24] . FGF23 increases renal phosphate excretion via transcriptional downregulation of the SLC34a1 gene encoding for the sodium-dependent phosphate transporter, NaPi2a, as well as regulating its expression at the apical membrane of the proximal tubule of the kidney [50, 51] . As for renal calcium transport, it was shown that FGF23 regulates membrane trafficking of TRPV5 in the distal convoluted tubule [52] .
FGF23 is produced by osteoblasts and osteocytes and is a member of the endocrine subfamily of FGFs. Production of FGF23 is primarily regulated by circulating levels of 1,25(OH) 2 D 3 . This notion is based on the observation that mice treated with 1,25(OH) 2 D 3 exhibit a rapid increase in FGF23 serum levels, while Vdr −/− mice have undetectable serum levels of FGF23 [53] . Indeed, 1,25(OH) 2 D 3 is responsible for a rapid induction of FGF23 transcription, likely via vitamin D response elements in close proximity to the FGF23 gene [54] . Some VDR-independent mechanisms are also reported to affect the expression of FGF23, such as local bone regulation by other FGFs, dietary phosphate, and PTH levels. However, their relative contributions to FGF23 expression levels compared to 1,25(OH) 2 D 3 is rather small, except for pathological situations [54] . In any case, FGF23 regulation is complex and multifactorial and exact molecular mechanisms that govern FGF23 expression in pathophysiology are important questions for future research. All members of the endocrine subfamily signal via FGF-receptors and require a co-factor from the Klotho family to initiate binding and downstream signaling. The anti-aging hormone αKlotho was identified as the obligatory co-factor for FGF23 [55] . It is a single-pass transmembrane protein, mainly expressed in the renal distal convoluted tubules and in the brain choroid plexus. However, klotho has two isoforms and exists either as a full-length transmembrane protein or as a smaller soluble factor that is present in serum [56] . The full-length form causes a conformational change in the c-isoforms of the FGFRs 1, 3, and 4, to turn them into high affinity FGF23 receptors [57] . Since αKlotho is required for the affinity change that allows the binding of FGF23 to its receptor, FGF23 target organs are restricted to tissues that co-express αKlotho and FGFRs, such as the kidney. This is confirmed by the notion that kidney-specific klotho knockout mice show a comparable phenotype as the systemic klotho knockout mice, exhibiting hyperphosphatemia, hypercalcemia, and increased 1,25(OH) 2 D 3 and FGF23 levels [58] . Interestingly, αKlotho is mainly expressed in the distal tubules, while renal phosphate reabsorption and vitamin D activation primarily take place in the proximal tubules [59] . Therefore, it is still a matter of debate how αKlotho mediates its effect on phosphate homeostasis. Within calcium homeostasis, αKlotho contributes to the suppression of PTH and 1,25(OH) 2 D 3 through its action with FGF23. Furthermore, soluble αKlotho directly increases renal calcium reabsorption by stabilizing TRPV5 at the epithelial membrane [60] . Chang et al. demonstrated β-glucuronidase activity for secreted αKlotho that affects the glycosylation of TRPV5 [60] . A later study proposed that αKlotho has sialidase activity and demonstrated that removal of end-standing sialic acids on glycosylated TRPV5 could enhance the binding of galectin, resulting in cell surface retention of the channel [61] . Recently, it is also suggested that membranous αKlotho can promote trafficking of TRPV5 through intracellular modification of the glycan [62] .
3. The building blocks of TRPV5 and TRPV6
Connecting two worlds requires a special type of ion channel
In the sections above, we illustrated the involvement of multiple organs, several hormones and many additional molecules that have to interact to keep serum calcium levels balanced. Multiple factors are usually present at the same time, which all signal to produce a combined calcium transport response. As mentioned before, the TRP channel polymodal activity profile allows them to fulfill a prominent role in these pathways. The question remains, how do they do it? In the sections below, the structure-function relationships of TRPV5 and TRPV6 will be discussed. Understanding how the channels are build contributes to a better understanding of their function and may shed new light on their roles within calcium homeostasis.
Overall architecture of the channels
Similar to all TRP channels, TRPV5 and TRPV6 form functional channels through tetramerization of individual subunits. The recently resolved structures of TRPV1, TRPV2 and TRPV6 provide the first steps towards understanding the structure-function of TRP channels [63] [64] [65] . From a front view, the channel follows a clover-like shape with a transmembrane stem and four petals, tightly connected and facing down into the cytoplasm to form the intracellular domain (Fig. 2) . Six alpha helices make up the transmembrane domain that crosses the lipid bilayer. The loop between the fifth and the sixth transmembrane domain faces inwards and downwards and is called the pore-forming loop. The extracellular domain of the pore-forming loop governs the ion selectivity of the channel and attracts cations towards the channel pore. It is thought that the carboxy-terminal regions are fixed to the interior of the channel, hanging down into the cytoplasm. This orientation allows post-translational modifications and protein binding. The aminoterminal region of each subunit forms one of the petals of the clover and has been linked to channel assembly and allosteric modulation of the pore region.
The channel assembly domain; stabilizing properties via interacting elements.
An intricate mesh of interactions, both within and between subunits, facilitates the assembly of four subunits into tetrameric ion channels. Researchers initially focused on the ankyrin repeat domain (ARD) in the TRPV amino-terminus as the possible channel assembly domain (Fig. 3) since this highly conserved helix-loop-helix structure is often involved in protein-protein interactions. Indeed, the ARD of TRPV6 plays a role in channel assembly, as in vitro data demonstrated that amino-terminal constructs of the channel are able to interact with the full-length channel. More specifically, the third ankyrin repeat and third finger loop appear essential, as deletion of these regions significantly affected the pull-down efficiency [66] . Using a similar pull-down experiment, the pre-ARD region of the TRPV5 amino terminus (residues 1-75) was linked to channel assembly [67] . A later study demonstrated that deletion of the first 38 amino acids produces non-functional channels, while tetramerization is unaffected [68] . Furthermore, the authors identified two residues, glutamine (Q 31 ) and aspartic acid (D 34 ), which are essential for correct folding and proper channel function [68] . A similar loss of channel function has been reported for TRPM8, upon deletion of a small part of the amino terminus (amino acids . Immunostaining of insect cells transfected with TRPM8 deletion mutants showed a defective pattern of retention in the endoplasmic reticulum and loss of staining at the plasma membrane [69] . However, deletion of the preankyrin repeat regions of TRPV1 and TRPV4 does not affect localization of these channels [70] . These contrasting results could be explained by differences in TRP channel folding mechanisms (pre-ARD alpha helix). Additionally, amino-terminal sorting motifs or binding sequences may direct the TRP channels to the plasma membrane. This has recently been shown to play a role in the membrane targeting of TRPC4 [71] .
While these early functional studies provided some insight into TRPV5 and TRPV6 channel assembly, they are unfit to elucidate the structural mechanisms that underlie this process. Instead, structural analysis of the channels was needed to identify the inner workings of the channels. Crystallization of the ARD has been performed for most of the TRPV members. The structural models revealed that the six tandem copies of the TRPV ARD produce a somewhat atypical ARD that deviates from the canonical structure at two sites. Firstly, the finger loop lengths of the TRPV ARD are considerably longer, which is particularly noticeable in the third finger loop [72, 73] . In addition, there is an unusual twist between the fourth and the fifth ankyrin repeat [72] . Within these crystallization studies, purified TRPV5 and TRPV6 ARDs were unable to self-assemble in solution, suggesting that additional structures are involved. Thus, crystal structures were unfit to study channel assembly, though they have shed new light on various ligand binding sites and possible mechanisms for channel regulation. Recently, advances in the fields of cryo-electron microscopy and Xray crystallography have allowed researchers to construct structural density maps for several members of the TRPV subfamily, using (close to) full-length constructs. The first example was TRPV1, revealing a near-atomic resolution of the channel structure [63] . Here, the authors showed that multiple domains within the amino-and carboxy termini interact to facilitate channel assembly. Within every individual subunit, there are two domains present that are involved in channel assembly; the ARD and the amino-terminal linker domain. The latter connects the ARD to the first transmembrane domain (S1) and is comprised of a beta-hairpin structure with two beta-sheets (B1 and B2), a helixturn-helix and the pre-S1 helix (Fig. 3) . One additional beta-sheet, originating from a six-residue stretch on the carboxy terminus, interacts with the beta-hairpin structure in the linker to form a three-stranded beta-sheet. This interaction between the linker domain and the carboxy terminus within an individual subunit may provide stability and direct the carboxy terminus towards the center of the channel, where it is available for binding by intracellular factors. Every subunit interacts with its neighbors through tangles of hydrogen bonding, salt bridging and hydrophobic interactions. All structural density maps of TRPV channels show interactions between the third ankyrin repeat, fourth ankyrin repeat and third finger loop of one subunit with the three-stranded beta-sheet in the linker domain of a neighboring subunit [63] [64] [65] 74] . Two residues that produce the sharp turn within the amino-terminal part of the beta-hairpin, a glycine and a proline, are present in all members of the TRPV subfamily, further underlining the importance of the connection between the ARD and the three-stranded beta sheet structure of the linker.
Of particular interest is that both structural density maps of TRPV1 and TRPV2 lack the pre-ARD amino terminus, which is either removed to improve stability or because no density was detected for this stretch, suggesting a lack of order in this region [63, 64, 74] . In contrast, the recent structural map for TRPV6 reveals a pre-ARD alpha helix at the center of the channel assembly domain, confirming the observations made in the earlier TRPV5 amino-terminal deletion study [65, 68] . This helix likely connects to the three-stranded beta sheet by salt bridges and hydrogen bonds, which involves residue D 34 (Fig. 3) . Besides these connections, residue Q 31 in the pre-ARD alpha helix also interacts with the pre-S1 helix of a neighboring subunit. The TRPV6 structural density map also demonstrates a carboxy-terminal hook that connects the carboxy terminus of one subunit to the pre-ARD alpha helix of a neighboring subunit [65] . These two features appear to be specific to TRPV5 and TRPV6 channels, based on the lack of density for the pre-ARD alpha helix in TRPV1 and TRPV2 maps [64, 75] . The functional implications of these diversities in TRPV architecture are not yet investigated to our knowledge, but may contribute to the specific roles of TRPV5 and TRPV6 in epithelial calcium transport.
The permeation pathway; calcium selectivity is the first step
The pore of TRPV channels bears resemblance to that of other ion channels, such as voltage-gated potassium, sodium and calcium channels [76] . It consists of a selectivity filter, a hydrophobic cavity and a lower gate. One of the unique features of TRPV5 and TRPV6 is their highly calcium-selective conductivity profile, with a P Ca /P Na N 100 as opposed to a conductivity profile of P Ca /P Na ≈ 1-10 for the other TRPV channels [77] . A) into an alanine. The authors also observed an overall decrease in calcium permeation and a loss of voltage-dependent magnesium block, whilst monovalent permeation remained intact [78] . This data is further supported by the TRPV6 structural map, which shows that the side chains of D 541 point towards the pore axis to form a 4.6 Å ring of negative charges. This ring is believed to attract cations to the pore entrance [65] . Further analysis of the TRPV6 outer pore region by Saotome and colleagues yielded three phenylalanines just downstream of D 541 that may restrict the flexibility of D 541 , creating a rather rigid outer pore structure. This is in contrast with the more flexible outer pore structure of TRPV1 that only contains one phenylalanine [63, 65] . Not surprisingly so, since ligand-mediated TRPV1 activation requires a higher degree of flexibility that enables the selectivity filter to change between open and closed conformations. Further illustrating the increased flexibility of the TRPV1 outer pore region compared to TRPV5/6 is the ability of TRPV1 to allow passage of large cations after long-lasting agonist activation, referred to as pore dilation. Indeed, the restricting methionine of the TRPV1 selectivity filter, together with the pore turret, a stretch of amino acids in the outer pore domain, are involved in this process [79] . The pore turret, which is located upstream of the selectivity filter in TRPV1, is a highly divergent region within the TRPV sequence and is completely absent from TRPV5/ 6. Therefore, sequence differences in the selectivity filter, coupled with the flexibility of the outer pore may explain the differences in calcium selectivity between TRPV5/6 and TRPV1-4. Saotome and colleagues have proposed a mechanism of calcium permeation, in which there are three binding sites. Site 1 (D 541 ) requires constitutive binding of calcium due to charge clashes between the B A Fig. 3 . Channel assembly domain. A) TRPV5 model depicting the structural link between the amino-terminal helix, the ankyrin repeats (ARDs), the (ARD-S1) linker domain, and the pre-S1 helix that is important for channel assembly. B) Zoomed view of the amino terminal domain showing the localisation of the two residues (Q 31 and D
34
) that were found to play a role in channel folding and assembly. D 541 side chains in the absence of the cation. This suggests a so-called 'knock-off' mechanism, in which a high local calcium concentration can push (and replace) a calcium ion from site 1. Subsequently, this ion moves to site 2 located just below the filter, which might serve as an intermediate hatch for site 3. This latter site is the lower gate (M 577 ) as outlined below, which is thought to be the final step towards calcium entry into the cell. Some caution is needed here, as TRPV6 was resolved in closed conformation and information concerning channel gating remains incomplete [65] .
The lower gate; mechanisms that open the channel
Below the selectivity filter, the TRPV pore area widens into a large hydrophobic cavity (13 Å in TRPV6), which is capable of holding a hydrated calcium ion. Similar to voltage-gated sodium channels, the hydrophobic cavity is connected to the lipid bilayer via fenestrations, that may allow small molecules or lipids to enter the cavity and regulate channel activity [65, 80] . Beyond the hydrophobic cavity, the helices of the sixth transmembrane domains cross, resulting in a constriction point at residue 577 in TRPV6 (Fig. 4) . Here, the side chains of the methionine (M 577 ) protrude into the central pore axis, similar to the equivalent methionine in TRPV2 [64, 65] . In contrast, the lower gate in TRPV1 is formed by an isoleucine (I 679 ) that is located closer to the selectivity filter and further away from the S6 helix bundle crossing. It is thought that allosteric opening of the lower gate plays a pivotal role in TRPV channel activation. The most extensively studied method of opening the lower gate is ligand-induced gating of TRPV1. Binding of the strong vanilloid compound resiniferatoxin (RTx) to a binding pocket close to the S4-S5 linker causes a rotation in the pore helix that opens the lower gate. Capsaicin, a vanilloid compound found in chili peppers, also binds the vanilloid pocket and rotates the pore helix. Interestingly, this rotation follows a direction opposite to RTx and causes a less pronounced opening of the channel pore (9.3 Å diameter for RTx compared to a 7.6 Å diameter for capsaicin) [81] .
While vanilloid sensitivity is not conserved in other TRPV channels it could be induced in TRPV2 via two point mutations in the vanilloid binding pocket, suggesting that gating via the S4-S5 linker is still present [82] . In fact, channel gating via the S4-S5 linker appears a likely candidate for most TRP channels, albeit initiated differently. Zubcevic et al. proposed a mechanism in which opening of the TRPV2 lower gate involves subsequent rotation of the ARD domain, linker domain and the carboxy-terminal TRP domain, which then rotate the pore helix to open the gate in a similar way as vanilloid activation in TRPV1 [64] . This idea is strengthened by two recent papers on TRPV4 and TRPV3 human disease mutations. Mutations in TRPV4 are known to cause peripheral neuropathy and/or skeletal dysplasia, likely caused by an increased single channel activity of mutant channels. Based on a TRPV4 homology model, authors showed a bond between residues W733 in the TRP domain and L596 in the S4-S5 linker that keeps the channel gate closed [83] . A specific human mutation, L596P, distorts the structure and weakens the L596-W733 bond, thereby destabilizing the closed state of the channel and explaining the increased channel activity and the observed gain-of-function phenotype [83] . In addition, specific genetic variants of the TRP box tryptophan and S4-S5 linker in TRPV3 (W692G and G573C respectively) have been linked to congenital Olmsted syndrome [84, 85] . They were shown to cause significantly enhanced channel activity, suggesting the mutations disturb the so-called gating bond and hold the channel in an open state [84] .
When looking at the TRPV6 structural density map, it is important to note the absence of density for the S4-S5 linker. This has created a conformation in which the pore domains of every subunit are packed against the S1-S4 domain of the same subunit [65] . In contrast, the TRPV1 and TRPV2 structures reveal a conformation in which the pore domains are swapped, meaning that they are packed against the S1-4 of a neighboring subunit [63, 64] . Hence, for the constitutively opened channels TRPV5 and TRPV6, the lower gate may not be opened in exactly the same fashion, and little is known about their gating mechanism, both on the structural and functional level. 
The carboxy terminus; regulatory role in channel function
The most important hallmark of TRP channels is located in the carboxy-terminal domain: the TRP domain (Fig. 2) . This is a~25-residue long region that follows just after the sixth transmembrane segment and contains a highly conserved TRP box that is involved in channel gating [86] [87] [88] [89] .
The exact functional role of the TRP box in TRPV5 and TRPV6 is unclear, but is proposed to act as a sensor for PIP 2 levels [90] . Regulation of TRP channel gating by PIP 2 and other phosphoinositides is widespread throughout the superfamily and differences in observed effects may be due to experimental conditions or channel-specific lipid interactions (reviewed in [91] ). It is thought that TRPV5/6 are stabilized by PIP 2 , which helps the channels to maintain their open conformation. A recent paper shows that a glycine residue (G 488 ), located between the fourth and fifth transmembrane domain, is involved in PIP 2 affinity for TRPV5 and TRPV6 [92] . However, the exact association between PIP 2 and the TRP box, as well as the structural implication of PIP 2 binding to its binding pocket in TRPV5/6 are not yet identified. Structurally, the TRP domain adopts an alpha-helical turn that runs at the inner membrane-cytosol interface beneath the fourth and fifth transmembrane domains. It lies between the helix-loop-helix linker domain and the pre-S1 helix (Fig. 2 ) that connects to the ARD, and can thereby function as a structural communication bridge between the transmembrane helices and the intracellular domains. From the TRPV1 structure it seems that tight interactions between these domains are important for opening of the lower gate, a phenomenon that is not observed in the TRPV2 and TRPV6 structural maps [64, 65, 81] . In addition, it was recently shown that lipid interactions in close proximity to the TRP domain stabilize the TRPV1 channel in a resting state, by occupying the binding pocket for antagonist binding [93] . Future studies should focus at reconstituting TRPV5 and TRPV6 into liposomes or nanodiscs, small lipid compartments, to determine the channel regulation by lipid binding.
After the TRP domain, the carboxy-terminal tail forms an extended loop, consisting of a beta sheet that interacts with a beta sheet of the linker domain and a motif in the ARD (Fig. 2) [65, 74, 81] . This suggests that the carboxy terminus supports the linker domain in regulating subunit assembly and in linking intracellular and transmembrane regions. Its role in channel assembly has long been postulated based on several reports demonstrating in vitro multimerization of purified recombinant carboxyl tails of TRPV1 [94, 95] . Furthermore, it has been demonstrated for several TRPV channels that (partial) truncation of the carboxy terminus affects the functional properties of the channel [96] [97] [98] . For TRPV5, the carboxy terminus plays an important role in channel regulation. First, Yeh et al. demonstrated that TRPV5 can be inhibited by intracellular acidification, suggested to occur through a conformational change of the pore helix leading to closing of channel via narrowing the upper gate (selectivity filter). They identified lysine 607 (L 607 ) as binding residue for protons [99] . Second, the PKA phosphorylation site T 709 of TRPV5 was identified as regulatory mechanism for parathyroid hormone stimulation. Phosphorylation of T 709 was shown to increase the open probability of single TRPV5 channels [100] . Third, TRPV5 plasma membrane abundance can be stabilized by tissue kallikrein, a serine protease in the kidney, that activates PKC signaling resulting in phosphorylation of serine 564 (Ser 654 ) in the TRPV5 carboxy terminus [101] . Fourth, the TRPV5 (and TRPV6) carboxy terminus was shown to interact with a several auxiliary proteins, like S100A10, NHERF2, and Rab11a, that affect channel trafficking and stabilization [102] [103] [104] . Another study demonstrated the importance of a positively charged histidine residue (His 712 ) in the regulation of TRPV5 function. Substitution into a negative aspartic acid (H 712 D) resulted in delayed internalization and thereby increased TRPV5 channel activity [96] . Finally, the carboxy terminus is involved in calcium-dependent channel inactivation. This was shown to depend on two calcium-sensing motifs, one between residues 650 and 653 and the other in the last 30 residues [105] . Calciumdependent inactivation was shown to rely on calmodulin binding to the carboxy terminus [38] [108] . However, to decipher the gating mechanism of calmodulin-dependent calcium inactivation in TRPV5, more structural data are required. Resolving the complete structure of the carboxy terminus has proven difficult so far, likely due to the high flexibility in this region.
Conclusions
Our knowledge of the molecular regulation of renal calcium handling has greatly increased over the past decade. Specific hormones (PTH, Vitamin D, and FGF23/Klotho) control the calcium balance through an intricate network of feedback mechanisms within the bone-kidney-parathyroid system. While PTH and vitamin D have long been established as calciotropic hormones, the more recent discoveries on the roles of FGF23 and αKlotho have revolutionized our understanding of calcium homeostasis and established a PTH-vitamin D-FGF23 axis. While significant progress is made in elucidating the pathophysiology and genetic abberations of these hormones in calcium-related disorders, challenges remain regarding the cause-and-effect mechanism. The relationship between the hormones is complex and multi-organ feedback together with the kinetics of each hormone complicates isolation of specific roles. Current studies focus on combining different (inducible) knockout mouse models to define how each hormone exerts its effects on other hormones and ultimately provide a full understanding of their role in maintaining the mineral balance. This will contribute to the diagnosis and treatment regime for diseases associated with calcium disturbances.
Recent technological breakthroughs transformed the single particle cryo-EM to a powerful technique for the high-resolution structure determination of large membrane proteins. The structural study of the first TRPV channels (TRPV1, TRPV2, and TRPV6) has provided valuable mechanistic insight into the architecture of these ion channels, and delivered novel ideas on channel permeation and gating mechanisms. Though, the conclusions can be controversial as the conformation of the ion channel is sensitive to the experimental conditions and interaction regions are likely dependent on the activation state of the channel. This emphasizes the need for corroborating the structural results with functional analysis of the ion channel.
With this review, we provide an up-to-date overview of the clinical and fundamental knowledge on calcium homeostasis and in particular, on the molecular functioning of the epithelial calcium channels TRPV5 and TRPV6.
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